4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-035975
EVP, Research & CSO sold 3,805 shares at $36.28 ($138,030)
- EVP, Research & CSO acquired 3,805 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-06-09 | Option exercise | +3,805 | $1.53 | $5,822 | 3,805 | D |
| Virgin Herbert EVP, Research & CSO | 2020-06-09 | Sale | −3,805 | $36.28 | $138,030 | 0 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2020-06-09 | Option exercise · Stock Option (Right to Buy) | −3,805 | 542,385 | D | ||
| Open-market sales · 3,805 sh · avg $36.28 · $138,030 | |||||||
Loading xslF345X03/doc4.xml…